These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 39273651)

  • 1. Mitochondria and Acute Leukemia: A Clinician's Perspective.
    Iyer P; Jasdanwala SS; Bhatia K; Bhatt S
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
    Glytsou C; Chen X; Zacharioudakis E; Al-Santli W; Zhou H; Nadorp B; Lee S; Lasry A; Sun Z; Papaioannou D; Cammer M; Wang K; Zal T; Zal MA; Carter BZ; Ishizawa J; Tibes R; Tsirigos A; Andreeff M; Gavathiotis E; Aifantis I
    Cancer Discov; 2023 Jul; 13(7):1656-1677. PubMed ID: 37088914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
    Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
    Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia.
    Olivas-Aguirre M; Pottosin I; Dobrovinskaya O
    J Leukoc Biol; 2019 May; 105(5):935-946. PubMed ID: 30698851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation.
    Enzenmüller S; Niedermayer A; Seyfried F; Muench V; Tews D; Rupp U; Tausch E; Groß A; Fischer-Posovszky P; Walther P; Stilgenbauer S; Kestler HA; Debatin KM; Meyer LH
    Cell Death Dis; 2024 Jul; 15(7):475. PubMed ID: 38961053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
    Bhatt S; Pioso MS; Olesinski EA; Yilma B; Ryan JA; Mashaka T; Leutz B; Adamia S; Zhu H; Kuang Y; Mogili A; Louissaint A; Bohl SR; Kim AS; Mehta AK; Sanghavi S; Wang Y; Morris E; Halilovic E; Paweletz CP; Weinstock DM; Garcia JS; Letai A
    Cancer Cell; 2020 Dec; 38(6):872-890.e6. PubMed ID: 33217342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
    Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
    Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A
    Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
    Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
    Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation.
    Zhang S; Zhang Y; Zhuang Y; Wang J; Ye J; Zhang S; Wu J; Yu K; Han Y
    PLoS One; 2012; 7(10):e46853. PubMed ID: 23056487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
    Rodrigo R; Mendis N; Ibrahim M; Ma C; Kreinin E; Roma A; Berg S; Blay J; Spagnuolo PA
    Autophagy; 2019 May; 15(5):900-907. PubMed ID: 30563411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells.
    Opydo-Chanek M; Rak A; Cierniak A; Mazur L
    Toxicol In Vitro; 2017 Aug; 42():38-46. PubMed ID: 28366708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel thiosemicarbazone as a promising effective and selective compound for acute leukemia.
    Perondi DM; Jacques AV; Stefanes NM; Maioral MF; Sens L; Pacheco LA; Cury NM; Nunes RJ; Yunes JA; Santos-Silva MC
    Anticancer Drugs; 2019 Sep; 30(8):828-837. PubMed ID: 30932944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs.
    Ishizawa J; Kojima K; McQueen T; Ruvolo V; Chachad D; Nogueras-Gonzalez GM; Huang X; Pierceall WE; Dettman EJ; Cardone MH; Shacham S; Konopleva M; Andreeff M
    PLoS One; 2015; 10(9):e0138377. PubMed ID: 26375587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative potential of a novel parthenin analog P16 as evident by apoptosis accompanied by down-regulation of PI3K/AKT and ERK pathways in human acute lymphoblastic leukemia MOLT-4 cells.
    Goswami A; Shah BA; Kumar A; Rizvi MA; Kumar S; Bhushan S; Malik FA; Batra N; Joshi A; Singh J
    Chem Biol Interact; 2014 Oct; 222():60-7. PubMed ID: 25196075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
    Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cx25 contributes to leukemia cell communication and chemosensitivity.
    Sinyuk M; Alvarado AG; Nesmiyanov P; Shaw J; Mulkearns-Hubert EE; Eurich JT; Hale JS; Bogdanova A; Hitomi M; Maciejewski J; Huang AY; Saunthararajah Y; Lathia JD
    Oncotarget; 2015 Oct; 6(31):31508-21. PubMed ID: 26375552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells.
    Maioral MF; Stefanes NM; Bigolin Á; Zatelli GA; Philippus AC; de Barcellos Falkenberg M; Santos-Silva MC
    Invest New Drugs; 2019 Oct; 37(5):912-922. PubMed ID: 30569243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Newly Synthetized Ferrocenyl Derivative Selectively Induces Apoptosis in ALL Lymphocytes through Mitochondrial Estrogen Receptors.
    Aghvami M; Pourahmad J; Zarghi A; Eshghi P; Zarei MH; Farzaneh S; Sattari F
    Anticancer Agents Med Chem; 2018; 18(7):1032-1043. PubMed ID: 29210666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.
    Zhai Y; Tang Q; Fang DD; Deng J; Zhang K; Wang Q; Yin Y; Fu C; Xue SL; Li N; Zhou F; Yang D
    Clin Cancer Res; 2023 Jan; 29(1):183-196. PubMed ID: 36240005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.